EUVIMEDEUVIMED entdecken
Crossref

Antibiotic use and risk of Clostridioides difficile infection in patients with inflammatory bowel disease

Alexis Bejcek iD, Anupama Ancha, Megan Lewis, Ryan Beaver, Kristen Tecson, Jaccallene Bomar, Christopher Johnson

Journal of Gastroenterology and Hepatology · 2024

DOI: 10.1111/jgh.16720 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2024. Verfasst von Alexis Bejcek und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Medicine, Baylor Scott & White Medical Center, Temple, Texas, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Clostridium Infections, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Baylor Scott & White Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim Patients with inflammatory bowel disease (IBD) have an increased risk of Clostridioides difficile infection (CDI) compared with those without IBD, which is worsened with antibiotic usage. While prior studies have shown a correlation between CDI development and certain classes of antibiotics, the IBD population has not been well represented. This study evaluates the rates of CDI with outpatient antibiotic use in patients with IBD.

Methods

We conducted a retrospective cohort study composed of patients with IBD and compared the incidence of CDI in patients who received an outpatient prescription for antibiotics (6694 patients) against those without prescriptions (6025 patients) from 2014 to 2020 at our institution. We compared CDI rates based on nine antibiotic classes: penicillins, cephalosporins, sulfonamides, tetracyclines, macrolides, quinolones, clindamycin, metronidazole, and nitrofurantoin.

Results

The risk of CDI was low (0.7%) but significantly higher for those with antibiotic exposure (0.9% vs 0.5%, P = 0.005) and had a positive correlation with a smoking history. The increased risk of CDI in the IBD population was attributable to the clindamycin and metronidazole classes (odds ratio = 4.7, 95% confidence interval: 1.9–11.9, P = 0.001; odds ratio = 3.6, 95% confidence interval: 2.1–6.2, P < 0.0001, respectively).

Conclusions

The use of clindamycin or metronidazole prescribed in an outpatient setting was associated with a statistically significant increased risk of CDI in patients with IBD. Although the association between clindamycin and CDI is a well‐established and common finding, the association between metronidazole and CDI is unique in this study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsClostridium InfectionsInflammatory Bowel DiseasesHumansRetrospective StudiesMaleFemaleMiddle AgedAdultIncidenceMetronidazoleRiskCohort StudiesClindamycinClostridioides difficileRisk FactorsAged

Stichwörter der Autor:innen

Clostridioides difficileantibioticsinflammatory bowel disease

Substanzen

Anti-Bacterial AgentsMetronidazoleClindamycin

Autor:innen und Institutionen

  • Division of Gastroenterology, Department of Medicine, Baylor Scott & White Medical Center, Temple, Texas, USA.
  • Division of Internal Medicine, Department of Medicine, Baylor Scott & White Medical Center, Temple, Texas, USA.
  • Division of Infectious Diseases, Department of Medicine, Baylor Scott & White Medical Center, Temple, Texas, USA.
  • Baylor Scott & White Research Institute, Baylor Scott & White Health, Dallas, Texas, USA.
  • Department of Medicine, Baylor College of Medicine, Temple, Texas, USA.

ORCID-Profile: Alexis Bejcek

Förderung

  • Baylor Scott & White Research Institute

Zitieren

APA

Bejcek, A., Ancha, A., Lewis, M., Beaver, R., Tecson, K., Bomar, J., & Johnson, C. (2024). Antibiotic use and risk of Clostridioides difficile infection in patients with inflammatory bowel disease. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16720

Vancouver

Bejcek A, Ancha A, Lewis M, Beaver R, Tecson K, Bomar J, et al. Antibiotic use and risk of Clostridioides difficile infection in patients with inflammatory bowel disease. Journal of Gastroenterology and Hepatology. 2024. doi:10.1111/jgh.16720

BibTeX
@article{Bejcek2024,
  author = {Bejcek, Alexis and Ancha, Anupama and Lewis, Megan and Beaver, Ryan and Tecson, Kristen and Bomar, Jaccallene and Johnson, Christopher},
  title = {Antibiotic use and risk of Clostridioides difficile infection in patients with inflammatory bowel disease},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2024},
  doi = {10.1111/jgh.16720}
}
Kostenlos starten →